Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.

Taouli B, Hoshida Y, Kakite S, Chen X, Tan PS, Sun X, Kihira S, Kojima K, Toffanin S, Fiel MI, Hirschfield H, Wagner M, Llovet JM.

Eur Radiol. 2017 Nov;27(11):4472-4481. doi: 10.1007/s00330-017-4844-6. Epub 2017 Apr 24.

2.

The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.

Ahn SM, Haq F, Park I, Nault JC, Zucman-Rossi J, Yu E.

BMC Cancer. 2018 May 18;18(1):571. doi: 10.1186/s12885-018-4192-1.

3.

Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging.

Chou CT, Chen RC, Lee CW, Ko CJ, Wu HK, Chen YL.

Br J Radiol. 2012 Jun;85(1014):778-83. doi: 10.1259/bjr/65897774. Epub 2011 Aug 9.

4.

Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.

Bhattacharjya S, Bhattacharjya T, Quaglia A, Dhillon AP, Burroughs AK, Patch DW, Tibballs JM, Watkinson AF, Rolles K, Davidson BR.

Dig Surg. 2004;21(2):152-9; discussion 159-60. Epub 2004 May 27.

PMID:
15166485
5.

Clinicopathological indices to predict hepatocellular carcinoma molecular classification.

Tan PS, Nakagawa S, Goossens N, Venkatesh A, Huang T, Ward SC, Sun X, Song WM, Koh A, Canasto-Chibuque C, Deshmukh M, Nair V, Mahajan M, Zhang B, Fiel MI, Kobayashi M, Kumada H, Hoshida Y.

Liver Int. 2016 Jan;36(1):108-18. doi: 10.1111/liv.12889. Epub 2015 Jun 29.

6.

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.

Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H, Thung SN, Bruix J, Newell P, April C, Fan JB, Roayaie S, Mazzaferro V, Schwartz ME, Llovet JM.

Gastroenterology. 2011 May;140(5):1501-12.e2. doi: 10.1053/j.gastro.2011.02.006. Epub 2011 Feb 12.

7.

Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.

Pan Q, Long X, Song L, Zhao D, Li X, Li D, Li M, Zhou J, Tang X, Ren H, Ding K.

Oncotarget. 2016 Jun 21;7(25):38487-38499. doi: 10.18632/oncotarget.9555.

8.

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.

Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, Watanabe G, Gabriel S, Friedman SL, Kumada H, Llovet JM, Golub TR.

Cancer Res. 2009 Sep 15;69(18):7385-92. doi: 10.1158/0008-5472.CAN-09-1089. Epub 2009 Sep 1.

9.

Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.

Kuo MD, Gollub J, Sirlin CB, Ooi C, Chen X.

J Vasc Interv Radiol. 2007 Jul;18(7):821-31.

PMID:
17609439
10.

Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Yoneda N, Matsui O, Kobayashi S, Kitao A, Kozaka K, Inoue D, Yoshida K, Minami T, Koda W, Gabata T.

Jpn J Radiol. 2019 Mar;37(3):191-208. doi: 10.1007/s11604-019-00817-3. Epub 2019 Feb 2. Review.

PMID:
30712167
11.

Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.

Wang Y, Liu H, Liang D, Huang Y, Zeng Y, Xing X, Xia J, Lin M, Han X, Liao N, Liu X, Liu J.

J Proteomics. 2017 Jan 6;150:230-241. doi: 10.1016/j.jprot.2016.09.008. Epub 2016 Sep 28.

PMID:
27693406
12.

CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.

Feng J, Zhu R, Chang C, Yu L, Cao F, Zhu G, Chen F, Xia H, Lv F, Zhang S, Sun L.

PLoS One. 2016 Mar 15;11(3):e0151501. doi: 10.1371/journal.pone.0151501. eCollection 2016.

13.

Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.

Moeini A, Sia D, Zhang Z, Camprecios G, Stueck A, Dong H, Montal R, Torrens L, Martinez-Quetglas I, Fiel MI, Hao K, Villanueva A, Thung SN, Schwartz ME, Llovet JM.

J Hepatol. 2017 May;66(5):952-961. doi: 10.1016/j.jhep.2017.01.010. Epub 2017 Jan 23.

14.

Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.

Miltiadous O, Sia D, Hoshida Y, Fiel MI, Harrington AN, Thung SN, Tan PS, Dong H, Revill K, Chang CY, Roayaie S, Byrne TJ, Mazzaferro V, Rakela J, Florman S, Schwartz M, Llovet JM.

J Hepatol. 2015 Dec;63(6):1368-77. doi: 10.1016/j.jhep.2015.07.025. Epub 2015 Jul 26.

15.

Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.

Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.

Oncotarget. 2015 Sep 22;6(28):25093-108. doi: 10.18632/oncotarget.4437.

16.

Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.

Matthai SM, Ramakrishna B.

Indian J Med Res. 2015 Oct;142(4):391-8. doi: 10.4103/0971-5916.169195.

17.

A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.

Shi M, Chen MS, Sekar K, Tan CK, Ooi LL, Hui KM.

Eur J Cancer. 2014 Mar;50(5):928-36. doi: 10.1016/j.ejca.2013.11.026. Epub 2013 Dec 11.

PMID:
24332572
18.

Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.

Likhitrattanapisal S, Tipanee J, Janvilisri T.

Tumour Biol. 2016 Sep;37(9):12755-12766. Epub 2016 Jul 22.

PMID:
27448818
19.

Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?

Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B.

AJR Am J Roentgenol. 2011 May;196(5):1083-9. doi: 10.2214/AJR.10.4720.

PMID:
21512074
20.

Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.

Ahn SY, Lee JM, Joo I, Lee ES, Lee SJ, Cheon GJ, Han JK, Choi BI.

Abdom Imaging. 2015 Apr;40(4):843-51. doi: 10.1007/s00261-014-0256-0.

PMID:
25253426

Supplemental Content

Support Center